Presently, Yael Margolin occupies the position of President of Gamida Cell, Inc.

She is also on the board of Ramot at Tel Aviv University Ltd., BiondVax Pharmaceuticals Ltd. and POINT Biopharma Global, Inc.

She previously was President & Director at Gamida Cell Ltd., Vice President for Denali Ventures LLC, Program Manager at Teva Pharmaceuticals USA, Inc. and Associate for Yale School of Medicine.

She received a doctorate from Weizmann Institute of Science and an undergraduate degree and a graduate degree from Tel-Aviv University.